SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of Young Innovations, Inc. (YDNT), Compuware Corp. (CPWR), Caribou Coffee Co. Inc. (CBOU) and Somaxon Pharmaceuticals (SOMX)

Tue Dec 18, 2012 12:19pm EST

* Reuters is not responsible for the content in this press release.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of Young Innovations, Inc. (YDNT), Compuware Corp. (CPWR), Caribou Coffee Co. Inc. (CBOU) and Somaxon Pharmaceuticals (SOMX)

PR Newswire

NEW YORK, Dec. 18, 2012 /PRNewswire/ --

Young Innovations, Inc.

Levi & Korsinsky is investigating the Board of Directors of Young Innovations, Inc. (NasdaqGS: YDNT) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to an affiliate of Linden Capital Partners for $39.50 per share. Young Innovations stock traded above the offer price as recently as September 27, 2012.

Click here to learn more about the investigation: http://zlk.9nl.com/young-innovations-ydnt/, or call: 877-363-5972.

(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO )

Compuware Corp.

Levi & Korsinsky is investigating the Board of Directors of Compuware Corp. (NasdaqGS: CPWR) for possible breaches of fiduciary duty and other violations of state law in connection with a going private proposal from Elliott Management Corp. ("Elliott") under which Elliott would acquire the outstanding shares of Compuware it does not currently own for a value of $11 per share.  At least one analyst set a price target for Compuware stock at $12.00 per share.

Click here to learn how to join the action: http://zlk.9nl.com/compuware-cpwr/, or call: 877-363-5972.

Caribou Coffee Co. Inc.

Levi & Korsinsky is investigating the Board of Directors of Caribou Coffee Co. Inc. (Nasdaq: CBOU) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Joh. A. Benckiser Group for $16 per share.

Click here to learn more about the investigation: http://zlk.9nl.com/caribou-coffee-cbou/, or call: 877-363-5972.

Somaxon Pharmaceuticals

Levi & Korsinsky is investigating the Board of Directors of Somaxon Pharmaceuticals, Inc. (NasdaqCM: SOMX) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Pernix Therapeutics Holdings, Inc. (NYSE MKT: PTX).

Click here to learn more about the investigation: http://zlk.9nl.com/somaxon-pharmaceuticals-somx/, or call: 877-363-5972.

Levi & Korsinsky is a national firm with offices in New York and Washington D.C.  The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits.  Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:      
Levi & Korsinsky, LLP 
Joseph Levi, Esq. 
30 Broad Street - 24th Floor  
New York, NY 10004  
Tel: (212) 363-7500 
Toll Free:  (877) 363-5972 
Fax: (866) 367-6510 
www.zlk.com 

SOURCE Levi & Korsinsky, LLP

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.